Bertrand Roy, Ph.D.

Bertrand Roy has led Medical Affairs at CSL Seqirus Canada since 2019. Before joining CSL Seqirus, Bertrand held several roles of increasing responsibility at Pfizer, Bayer and PRA Health Sciences, a comprehensive clinical development service provider to the life sciences sector. Bertrand’s Medical Affairs experience spans more than 22 years in various therapeutic areas such as Oncology, Infectious Diseases and Vaccines. His vaccine experience includes transitioning Wyeth’s vaccine portfolio to Pfizer following its acquisition. While at Pfizer, Bertrand was responsible for launching child and adult indications of its pneumococcal vaccine. Bertrand has a B.Sc. in biomedical sciences and an M.Sc. and Ph.D. in Pharmacology from the Université de Montréal, Canada.